Main
HTN & Chol (main page)
| 2025 AHA/ACC/SGIM Guideline for Prevention, Detection, Eval/Mgmnt HTN Adults
|
| Treatment and Outcomes of Inpatient Hypertension Among Adults with noncardiac admissions
|
| CHOL: 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD in Pts w/Hypertriglyceri
|
| CHOL: 2018 Guideline on the Management of Blood Cholesterol
|
| CHOL: ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC
|
| CHOL: ATP4 - 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic
|
| HTN: JNC8 - 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
|
| HTN: ONTARGET (2008): Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
|
| HTN: ACCORD (2008) Trial - Intensive vs standard control of HTN in Type 2 DM
|
| 4S (1995): The Scandinavian Simvastatin Survival Study
|
| HOPE Trial (2000): Effects of an Angiotensin-Converting Enzyme Inhibitor, Ramipril, on Cardiovascu
|
| ALLHAT (2002): Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Convertin
|
